However, insignificant differences were observed in anxiety, depression, disability, and quality of life between participants with positive and negative statuses for other analysed biomarkers such as anti-SM, DNA DC, ICAM positive, ANA, and Anti-RO. Here, BTG3 is linked to depressive symptom measurement.